tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mark Massaro, 291 are a BUY (85.34%), 40 are a HOLD (11.73%), 10 are a SELL (2.93%).
Analyst Mark Massaro, currently employed at BTIG, carries an average stock price target met ratio of 53.45% that have a potential upside of 32.82% achieved within 195 days.
Mark Massaro’s has documented 657 price targets and ratings displayed on 43 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CDNA, Caredx at 26-Feb-2026.
Analyst best performing recommendations are on TKNO (ALPHA TEKNOVA).
The best stock recommendation documented was for GHDX (GENOMIC HEALTH) at 11/7/2018. The price target of $82 was fulfilled within 2 days with a profit of $8.18 (9.07%) receiving and performance score of 45.35.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Oct-2020
$22
$7.14 (48.05%)
$19
1 months 4 days ago
(06-Feb-2026)
7/11 (63.64%)
$6.23 (39.51%)
82
Hold Since 09-Sep-2020
$16
$1.14 (7.67%)
$9
3 months 27 days ago
(11-Nov-2025)
8/8 (100%)
$1.47 (10.12%)
581
Buy Since 08-Aug-2023
$20
$5.14 (34.59%)
$15
4 months 23 days ago
(15-Oct-2025)
13/13 (100%)
$2.89 (16.89%)
269
Buy Since 21-Mar-2025
$10
$-4.86 (-32.71%)
$9
10 months 8 days ago
(02-May-2025)
5/6 (83.33%)
$0.16 (1.63%)
96
Buy Since 05-Jan-2023
$12
$-2.86 (-19.25%)
$15
1 years 25 days ago
(13-Feb-2025)
2/2 (100%)
$3.48 (40.85%)
570
Which stock is Mark Massaro is most bullish on?
Which stock is Mark Massaro is most reserved on?
What Year was the first public recommendation made by Mark Massaro?
